Loading…
Legislative Progress
Introduced
February 25, 2019
Latest Action
February 26, 2019
Primary Sponsor
Bruce WestermanRepublican(AR)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
1d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Fair Care Act of 2019 This bill addresses the health care system, including Medicare, Medicaid, the private health insurance market, and the prescription drug approval process. The bill also revises tax provisions related to certain health care costs and establishes requirements for lawsuits involving health care provided, at least in part, through a federal program or with federal funds.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (16)
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Military Personnel.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Judiciary, Oversight and Reform, Education and Labor, Rules, the Budget, Armed Services, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2023 · first_quarter · Health Issues
HR 457 Health Savings Account Act S 12 Health Savings Act of 2019 HR 3594 Healthcare Freedom Act of 2019 HR 1332 Fair Care Act of 2019 (CHRONIC) Care Act of 2017; Issues pertaining to chronic disease prevention in Medicare
Client expense: Not reported · Firm income: $23,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
S. 2574 Protects Act H.R. 3398 Pathways to Health Careers Act H.R.4468- Nursing Home Workforce Quality Act Outreach to Hill on GAO Report "Federal Requirements for Oversight in Nursing Homes and Assisted Living Facilities Differ" Outreach to CMS: PDPM Implementation Observation Stays Issue Outreach to HHS/CMS/Administration Skilled Nursing Facility Requirements of Participation, RIN 0938-AR61 Survey Relief/Civil Monetary Penalties Payroll Based Journal - Section 6106 of the Affordable Care Act Allow Secretarial discretion of CNA Training termination pertaining to Sec. 1819 (f)(2)(B)(iii)(l)(c). S 2943/HR 5216 Quality Care for Nursing Home Residents Act of 2019 HR 5326 Fairness in Nursing Home Arbitration Act H.R.5897/S.3297 - Preventing Abuse and Neglect of Vulnerable Americans Act of 2020 Public Law 116-136, CARES Act Public Law 116-127 (H.R. 6201) Families First Coronavirus Response Act HR 6800 HEROES Act S. 3768/H.R. 6972 Nursing Home COVID-19 Protection and Prevention Act of 2020. S. 4108 A bill to amend title XIX of the Social Security Act to increase Federal support to State Medicaid programs during economic downturns, and for other purposes. S.3644 Quality Care for Nursing Home Residents and Workers During COVID-19 Act of 2020. H.R. 7048 Nursing Home Pandemic Protection Act H.R.6872 - SOS Act of 2020 H.R. 6849 Nursing Facility Quality Reporting Act of 2020 H.R. 6847 COHORT Act of 2020 Public Health Fund Distribution to HHS as agency CMS on Public Health Waiver and other waivers RUSH Act H.R. 6209/S.3447 H.R. 8574 amend titles XVIII and XIX of the Social Security Act to increase enforcement under Medicare and Medicaid for skilled nursing facilities and nursing facilities during the COVID-19 emergency period and other infectious disease outbreak periods, and for other purposes. S. 4666 National Coronavirus Commission Act of 2020 AHCA response to Ways and Means Committee report Under-Enforced and Over Prescribed: The Antipsychotic Drug Epidemic Ravings Americas Nursing Homes. BENES Act (S 1280/HR 2477) H.R.331 - Nurses CARE Act of 2021 S.368 and H.R.1332 Telehealth Modernization Act Protecting Rural Telehealth Access Act (S.1988) Support for Provider Relief Funds (PRF) for long term care providers and outreach to HRSA and the Hill on PRF Rep. Terri Sewell Provider Relief Fund letter Re-introduction work of the Preventing Abuse and Neglect of Vulnerable Americans Act Improving Access to Medicare Coverage Act (H.R. 3650/S. 2048) SNF Payment Rule OSHA Emergency Temporary Standards Care For Our Seniors Act Infrastructure Proposal Long Term Care Advocacy AHCA monitoring Ways and Means Investigative and Oversight Subcommittee hearing on the role private equity plays in the skilled nursing facility sector. Medicare Advantage S.4862 - Supporting Our Seniors Act H.R.8832 - To amend title XI of the Social Security Act to ensure nursing facilities report information on medical directors of such facilities. CDC/COVID Safety Guidance
2022 · third_quarter · Medicare/Medicaid
S. 2574 Protects Act H.R. 3398 Pathways to Health Careers Act H.R.4468- Nursing Home Workforce Quality Act Outreach to Hill on GAO Report "Federal Requirements for Oversight in Nursing Homes and Assisted Living Facilities Differ" Outreach to CMS: PDPM Implementation Observation Stays Issue Outreach to HHS/CMS/Administration Skilled Nursing Facility Requirements of Participation, RIN 0938-AR61 Survey Relief/Civil Monetary Penalties Payroll Based Journal - Section 6106 of the Affordable Care Act Allow Secretarial discretion of CNA Training termination pertaining to Sec. 1819 (f)(2)(B)(iii)(l)(c). S 2943/HR 5216 Quality Care for Nursing Home Residents Act of 2019 HR 5326 Fairness in Nursing Home Arbitration Act H.R.5897/S.3297 - Preventing Abuse and Neglect of Vulnerable Americans Act of 2020 Public Law 116-136, CARES Act Public Law 116-127 (H.R. 6201) Families First Coronavirus Response Act HR 6800 HEROES Act S. 3768/H.R. 6972 Nursing Home COVID-19 Protection and Prevention Act of 2020. S. 4108 A bill to amend title XIX of the Social Security Act to increase Federal support to State Medicaid programs during economic downturns, and for other purposes. S.3644 Quality Care for Nursing Home Residents and Workers During COVID-19 Act of 2020. H.R. 7048 Nursing Home Pandemic Protection Act H.R.6872 - SOS Act of 2020 H.R. 6849 Nursing Facility Quality Reporting Act of 2020 H.R. 6847 COHORT Act of 2020 Public Health Fund Distribution to HHS as agency CMS on Public Health Waiver and other waivers RUSH Act H.R. 6209/S.3447 H.R. 8574 amend titles XVIII and XIX of the Social Security Act to increase enforcement under Medicare and Medicaid for skilled nursing facilities and nursing facilities during the COVID-19 emergency period and other infectious disease outbreak periods, and for other purposes. S. 4666 National Coronavirus Commission Act of 2020 AHCA response to Ways and Means Committee report Under-Enforced and Over Prescribed: The Antipsychotic Drug Epidemic Ravings Americas Nursing Homes. BENES Act (S 1280/HR 2477) H.R.331 - Nurses CARE Act of 2021 S.368 and H.R.1332 Telehealth Modernization Act Protecting Rural Telehealth Access Act (S.1988) Support for Provider Relief Funds (PRF) for long term care providers and outreach to HRSA and the Hill on PRF Rep. Terri Sewell Provider Relief Fund letter Re-introduction work of the Preventing Abuse and Neglect of Vulnerable Americans Act Improving Access to Medicare Coverage Act (H.R. 3650/S. 2048) SNF Payment Rule OSHA Emergency Temporary Standards Care For Our Seniors Act Infrastructure Proposal Long Term Care Advocacy AHCA monitoring Ways and Means Investigative and Oversight Subcommittee hearing on the role private equity plays in the skilled nursing facility sector. Medicare Advantage S.4862 - Supporting Our Seniors Act H.R.8832 - To amend title XI of the Social Security Act to ensure nursing facilities report information on medical directors of such facilities. CDC/COVID Safety Guidance
2022 · second_quarter · Medicare/Medicaid
S. 2574 Protects Act H.R. 3398 Pathways to Health Careers Act H.R.4468- Nursing Home Workforce Quality Act Outreach to Hill on GAO Report "Federal Requirements for Oversight in Nursing Homes and Assisted Living Facilities Differ" Outreach to CMS: PDPM Implementation Observation Stays Issue Outreach to HHS/CMS/Administration Skilled Nursing Facility Requirements of Participation, RIN 0938-AR61 Survey Relief/Civil Monetary Penalties Payroll Based Journal - Section 6106 of the Affordable Care Act Allow Secretarial discretion of CNA Training termination pertaining to Sec. 1819 (f)(2)(B)(iii)(l)(c). S. 2993- Ensuring Seniors Access to Quality Care Act S 2943/HR 5216 Quality Care for Nursing Home Residents Act of 2019 HR 5326 Fairness in Nursing Home Arbitration Act H.R.5897/S.3297 - Preventing Abuse and Neglect of Vulnerable Americans Act of 2020 Public Law 116-136, CARES Act Public Law 116-127 (H.R. 6201) Families First Coronavirus Response Act HR 6800 HEROES Act S. 3768/H.R. 6972 Nursing Home COVID-19 Protection and Prevention Act of 2020. S. 4108 A bill to amend title XIX of the Social Security Act to increase Federal support to State Medicaid programs during economic downturns, and for other purposes. S.3644 Quality Care for Nursing Home Residents and Workers During COVID-19 Act of 2020. H.R. 7048 Nursing Home Pandemic Protection Act H.R.6872 - SOS Act of 2020 H.R. 6849 Nursing Facility Quality Reporting Act of 2020 H.R. 6847 COHORT Act of 2020 Public Health Fund Distribution to HHS as agency CMS on Public Health Waiver and other waivers RUSH Act H.R. 6209/S.3447 H.R. 8574 amend titles XVIII and XIX of the Social Security Act to increase enforcement under Medicare and Medicaid for skilled nursing facilities and nursing facilities during the COVID-19 emergency period and other infectious disease outbreak periods, and for other purposes. S. 4666 National Coronavirus Commission Act of 2020 AHCA response to Ways and Means Committee report Under-Enforced and Over Prescribed: The Antipsychotic Drug Epidemic Ravings Americas Nursing Homes. BENES Act (S 1280/HR 2477) H.R.331 - Nurses CARE Act of 2021 S.368 and H.R.1332 Telehealth Modernization Act Protecting Rural Telehealth Access Act (S.1988) Support for Provider Relief Funds (PRF) for long term care providers and outreach to HRSA and the Hill on PRF Rep. Terri Sewell Provider Relief Fund letter Re-introduction work of the Preventing Abuse and Neglect of Vulnerable Americans Act Improving Access to Medicare Coverage Act (H.R. 3650/S. 2048) SNF Payment Rule OSHA Emergency Temporary Standards Care For Our Seniors Act Infrastructure Proposal Long Term Care Advocacy AHCA monitoring Ways and Means Investigative and Oversight Subcommittee hearing on the role private equity plays in the skilled nursing facility sector. Medicare Advantage
2022 · first_quarter · Medicare/Medicaid
S. 2574 Protects Act H.R. 3398 Pathways to Health Careers Act H.R.4468- Nursing Home Workforce Quality Act Outreach to Hill on GAO Report "Federal Requirements for Oversight in Nursing Homes and Assisted Living Facilities Differ" Outreach to CMS: PDPM Implementation Observation Stays Issue Outreach to HHS/CMS/Administration Skilled Nursing Facility Requirements of Participation, RIN 0938-AR61 Survey Relief/Civil Monetary Penalties Payroll Based Journal - Section 6106 of the Affordable Care Act Allow Secretarial discretion of CNA Training termination pertaining to Sec. 1819 (f)(2)(B)(iii)(l)(c). S. 2993- Ensuring Seniors Access to Quality Care Act S 2943/HR 5216 Quality Care for Nursing Home Residents Act of 2019 HR 5326 Fairness in Nursing Home Arbitration Act H.R.5897/S.3297 - Preventing Abuse and Neglect of Vulnerable Americans Act of 2020 Public Law 116-136, CARES Act Public Law 116-127 (H.R. 6201) Families First Coronavirus Response Act HR 6800 HEROES Act S. 3768/H.R. 6972 Nursing Home COVID-19 Protection and Prevention Act of 2020. S. 4108 A bill to amend title XIX of the Social Security Act to increase Federal support to State Medicaid programs during economic downturns, and for other purposes. S.3644 Quality Care for Nursing Home Residents and Workers During COVID-19 Act of 2020. H.R. 7048 Nursing Home Pandemic Protection Act H.R.6872 - SOS Act of 2020 H.R. 6849 Nursing Facility Quality Reporting Act of 2020 H.R. 6847 COHORT Act of 2020 Public Health Fund Distribution to HHS as agency CMS on Public Health Waiver and other waivers RUSH Act H.R. 6209/S.3447 H.R. 8574 amend titles XVIII and XIX of the Social Security Act to increase enforcement under Medicare and Medicaid for skilled nursing facilities and nursing facilities during the COVID-19 emergency period and other infectious disease outbreak periods, and for other purposes. S. 4666 National Coronavirus Commission Act of 2020 AHCA response to Ways and Means Committee report Under-Enforced and Over Prescribed: The Antipsychotic Drug Epidemic Ravings Americas Nursing Homes. BENES Act (S 1280/HR 2477) H.R.331 - Nurses CARE Act of 2021 S.368 and H.R.1332 Telehealth Modernization Act Protecting Rural Telehealth Access Act (S.1988) Support for Provider Relief Funds (PRF) for long term care providers and outreach to HRSA and the Hill on PRF Rep. Terri Sewell Provider Relief Fund letter Re-introduction work of the Preventing Abuse and Neglect of Vulnerable Americans Act Improving Access to Medicare Coverage Act (H.R. 3650/S. 2048) SNF Payment Rule OSHA Emergency Temporary Standards Care For Our Seniors Act Infrastructure Proposal Long Term Care Advocacy AHCA monitoring Ways and Means Investigative and Oversight Subcommittee hearing on the role private equity plays in the skilled nursing facility sector. Medicare Advantage
| Referred to |
| February 25, 2019 |
| Rules Committee | House | Referred to | February 25, 2019 |
| Education and the Workforce Committee | House | Referred to | February 25, 2019 |
| Oversight and Accountability Committee | House | Referred to | February 25, 2019 |
| Judiciary Committee | House | Referred to | February 25, 2019 |
| Ways and Means Committee | House | Referred to | February 25, 2019 |
| S 350 |
116th |
| Related bill |
| S 2860 | 116th | Related bill |
| HR 856 | 116th | Related bill |
| HR 8527 | 116th | Related bill |
| HR 803 | 116th | Related bill |
| HR 789 | 116th | Related bill |
| HR 506 | 116th | Related bill |
| HR 3972 | 116th | Related bill |
| HR 3947 | 116th | Related bill |
| HR 3062 | 116th | Related bill |
| HR 1922 | 116th | Related bill |
| HR 1418 | 116th | Related bill |
| HR 1035 | 116th | Related bill |
Client expense: $1,160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Client expense: $980,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Client expense: $940,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Client expense: $910,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2021 · first_quarter · Health Issues
HR 457 Health Savings Account Act S 12 Health Savings Act of 2019 HR 3594 Healthcare Freedom Act of 2019 HR 1332 Fair Care Act of 2019 (CHRONIC) Care Act of 2017; Issues pertaining to chronic disease prevention in Medicare
Client expense: Not reported · Firm income: $22,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · second_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.
Client expense: $2,160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies. Most Favored Nation (MFN) Model - (CMS-5528-IFC)
Client expense: $1,090,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Health Issues
Primary Care Enhancement Act CMS Primary Cares Demonstration HR 3708 To amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes. HR 856 Physician Pro Bono Care Act of 2019 HR 603 Health Savings Account Expansion Act of 2019 HR 457 Health Savings Account Act S 12 Health Savings Act of 2019 HR 3594 Healthcare Freedom Act of 2019 HR 1332 Fair Care Act of 2019
Client expense: Not reported · Firm income: $22,500
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
S. 474, Stop the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act; H.R. 447 / S. 97, Affordable and Safe Prescription Drug Importation Act; S. 61 / H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 102 / H.R. 465, Prescription Drug Price Relief Act of 2019; H.R.1478, Affordable Insulin Act of 2019; S. 3, Keeping Health Insurance Affordable Act of 2019; H.R 965 / S. 340, CREATES Act of 2019; H.R. 1332, Fair Care Act of 2019; S. 637, CURE High Drug Prices Act; H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019; S. 657, A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits; S. 709, Prescription Drug Pricing Dashboard Act; S. 977, Transparent Drug Pricing Act of 2019; S. 1895, Lower Health Care Costs Act; H.R. 2296, FAIR Drug Pricing Act of 2019; H.R. 3947, the Competition Prescription Act of 2019; H.R. 2279, the Safe Step Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, the Prescription Drug Pricing Reduction Act of 2019; H.R. 19 / S. 3129, the Lower Costs, More Cures Act of 2019; S. 4199, the Prescription Drug Pricing Reduction Act of 2020
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
2020 · fourth_quarter · Health Issues
Primary Care Enhancement Act CMS Primary Cares Demonstration HR 3708 To amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes. HR 856 Physician Pro Bono Care Act of 2019 HR 603 Health Savings Account Expansion Act of 2019 HR 457 Health Savings Account Act S 12 Health Savings Act of 2019 HR 3594 Healthcare Freedom Act of 2019 HR 1332 Fair Care Act of 2019
Client expense: Not reported · Firm income: $15,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies. Most Favored Nation (MFN) Model - (CMS-5528-IFC)
Client expense: $1,090,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · fourth_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act H.R.133 - Consolidated Appropriations Act, 2021 Phase 4 COVID-19 relief legislation H. R. 8702 - Holding Providers Harmless from Medicare Cuts During COVID-19 Act Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $10,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · fourth_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act H.R.133 - Consolidated Appropriations Act, 2021 Phase 4 COVID-19 relief legislation H. R. 8702 - Holding Providers Harmless from Medicare Cuts During COVID-19 Act Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $10,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · fourth_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act H.R.133 - Consolidated Appropriations Act, 2021 Phase 4 COVID-19 relief legislation H. R. 8702 - Holding Providers Harmless from Medicare Cuts During COVID-19 Act Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $308,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · fourth_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act H.R.133 - Consolidated Appropriations Act, 2021 Phase 4 COVID-19 relief legislation H. R. 8702 - Holding Providers Harmless from Medicare Cuts During COVID-19 Act Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $308,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · fourth_quarter · Health Issues
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 1035, Prescription Drug Price Transparency Act H.R. 1332, Fair Care Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1409, To promote transparency in health care pricing H.R. 2778, Healthy Maternity and Obstetric Medicine Act S. 1481, Healthy Maternity and Obstetric Medicine Act H.R. 2803, Access to Infertility Treatment and Care Act H.R. 3523, End Price Gouging for Medications Act S. 1987, End Price Gouging for Medications Act H.R. 3815, PrEP Access and Coverage Act H.R. 4158, CURE High Drug Prices Act H.R. 4493, Federal Employee Short-Term Disability Act H.R. 5551, Ensuring Child Health Coverage Compensation in Divorce Act of 2020 H.R. 6411, Emergency Advance Refill Notification Act of 2020 H.R. 6824, To amend the Internal Revenue Code of 1986 to provide for the carryover of the remaining 2020 balance in health flexible spending arrangements H.R. 7008, Family Savings Flexibility Act H.R. 7475, Ensuring FEHBP Coverage During Pandemic Act H.R. 7997, COVID-19 Health and Dependent Care Flexible Spending Account Distribution Act S. 4371, Fair FSAs Act of 2020
Client expense: $230,000 · Firm income: Not reported
Government targets: Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Federal Communications Commission (FCC), Federal Retirement Thrift Investment Board, Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Merit Systems Protection Board, Natl Park Service (NPS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Special Counsel, Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Customs & Border Protection
2020 · first_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
2020 · third_quarter · Health Issues
Primary Care Enhancement Act CMS Primary Cares Demonstration HR 3708 To amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes. HR 856 Physician Pro Bono Care Act of 2019 HR 603 Health Savings Account Expansion Act of 2019 HR 457 Health Savings Account Act S 12 Health Savings Act of 2019 HR 3594 Healthcare Freedom Act of 2019 HR 1332 Fair Care Act of 2019
Client expense: Not reported · Firm income: $15,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.
Client expense: $1,600,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · third_quarter · Health Issues
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 1035, Prescription Drug Price Transparency Act H.R. 1332, Fair Care Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1409, To promote transparency in health care pricing H.R. 2778, Healthy Maternity and Obstetric Medicine Act S. 1481, Healthy Maternity and Obstetric Medicine Act H.R. 2803, Access to Infertility Treatment and Care Act H.R. 3523, End Price Gouging for Medications Act S. 1987, End Price Gouging for Medications Act H.R. 3815, PrEP Access and Coverage Act H.R. 4158, CURE High Drug Prices Act H.R. 4493, Federal Employee Short-Term Disability Act H.R. 5551, Ensuring Child Health Coverage Compensation in Divorce Act of 2020 H.R. 6411, Emergency Advance Refill Notification Act of 2020 H.R. 6824, To amend the Internal Revenue Code of 1986 to provide for the carryover of the remaining 2020 balance in health flexible spending arrangements H.R. 7008, Family Savings Flexibility Act H.R. 7475, Ensuring FEHBP Coverage During Pandemic Act H.R. 7997, COVID-19 Health and Dependent Care Flexible Spending Account Distribution Act S. 4371, Fair FSAs Act of 2020
Client expense: $280,000 · Firm income: Not reported
Government targets: Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Federal Communications Commission (FCC), Federal Retirement Thrift Investment Board, Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Merit Systems Protection Board, Natl Park Service (NPS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Special Counsel, Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Customs & Border Protection
2020 · third_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Phase 4 COVID-19 relief legislation Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · third_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Phase 4 COVID-19 relief legislation Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · third_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Phase 4 COVID-19 relief legislation Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · third_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 7059: Coronavirus Provider Protection Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 - End Surprise Billing Act H.R. 3630 - No Surprises Act H.R. 3502 - Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 - Lower Health Care Costs Act S. 967 - Reducing Costs for Out of Network Services Act S. 1266 - Protecting Patients from Surprise Medical Bills Act S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act S. 1607 - Medical Billing Fairness Act H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953 - Pandemic Responder Service Award Act H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Phase 4 COVID-19 relief legislation Federal Incentive Programs COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) MIPS Value Pathways (MVPs) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · third_quarter · Health Issues
S. 474, Stop the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act; H.R. 447 / S. 97, Affordable and Safe Prescription Drug Importation Act; S. 61 / H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 102 / H.R. 465, Prescription Drug Price Relief Act of 2019; H.R.1478, Affordable Insulin Act of 2019; S. 3, Keeping Health Insurance Affordable Act of 2019; H.R 965 / S. 340, CREATES Act of 2019; H.R. 1332, Fair Care Act of 2019; S. 637, CURE High Drug Prices Act; H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019; S. 657, A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits; S. 709, Prescription Drug Pricing Dashboard Act; S. 977, Transparent Drug Pricing Act of 2019; S. 1895, Lower Health Care Costs Act; H.R. 2296, FAIR Drug Pricing Act of 2019; H.R. 3947, the Competition Prescription Act of 2019; H.R. 2279, the Safe Step Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, the Prescription Drug Pricing Reduction Act of 2019; H.R. 19 / S. 3129, the Lower Costs, More Cures Act of 2019; S. 4199, the Prescription Drug Pricing Reduction Act of 2020
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
2020 · second_quarter · Health Issues
Preserve Access to Affordable Generics Act (S. 64); Regulatory exclusivity; Drug pricing; Medicare Part B international reference pricing; Protecting Consumer Access to Generic Drugs Act of 2019 (H.R. 1499); Generic drug competition; Drug patent issues; Lower Health Care Costs Act of 2019 (S. 1895); STOP Stalling Act (S. 1224); Affordable Prescriptions for Patients Act of 2019 (S. 1416); Preserve Access to Affordable Generics and Biosimilars Act (H.R.2375); Protecting Access to Biosimilars Act of 2019 (H.R.2011/S. 1140); Drug importation; State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019 (H.R. 2038); Transparent Drug Pricing Act of 2019 (S.977); Medicare Negotiation and Competitive Licensing Act of 2019 (H.R. 1046); Medicare Prescription Drug Price Negotiation Act of 2019 (H.R. 275); Medicare Drug Price Negotiation Act (H.R. 448); Lower Drug Costs Now Act of 2019 (H.R. 3); Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019 (S.476); Fair Care Act of 2019 (H.R.1332); Prescription Drug Pricing Reduction Act of 2019 (S. 2543); Competition Prescription Act of 2019 (H.R. 3947); Fixing Global Freeloading Act (H.R. 2209); National Defense Authorization Act for Fiscal Year 2020 (S.1790); Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (HR 5133/HR 4398); STOP GAMES Act of 2019 (HR 2387); H.R.3666 - STRONGER Patents Act of 2019, H.R.19 - Lower Costs, More Cures Act of 2019, Pharmaceutical Independence Long-Term Readiness Reform Act (HR 4710); H.R. 3991 - Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019; Purple Book Continuity Act of 2019 (H.R. 1520); Biologic Patent Transparency Act (S. 659); Orange Book Transparency Act of 2019 (H.R. 1503); Prescription Drug Affordability and Access Act (S. 3166); Biosimilars user fees legislation; Lowering Prescription Drug Prices for Americas Seniors and Families Act (S. 3384); Anticompetitive Exclusionary Conduct Prevention Act of 2020 (S. 3426); Second Look at Drug Patents Act of 2019 (S. 1617); Priority review vouchers; MODERN Labeling Act of 2020 (HR 5668); Recall Unsafe Drugs Act of 2020 (HR 5578); Buy American Executive Order; Compulsory licensing; Strengthening Innovation in Medicare and Medicaid Act (H.R. 5741), No Ban Act (H.R. 2214/S. 1123); Benefit and Payment Parameters; Notice Requirement for Non-Federal Governmental Plans (85 Fed. Reg. 7088); Medical Supply Chain Security Act (S. 3343); Strengthening America's Supply Chain and National Security Act (S. 3538 / H.R.6393) Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), Drug recalls, registration and listing, expiration dating and shortages, and supply chain issues; Real world evidence; Presidential Proclamation 10052 of June 22, 2020; Taxpayer Research and Coronavirus Knowledge Act of 2020 (H.R.7288); Biosimilars user fee legislation; Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020 (HR 6260/S.3545); Make Medications Affordable by Preventing Pandemic Pricegouging Act of 2020 (H.R.7296); Strategic National Stockpile; Data Sharing; National Defense Authorization Act for Fiscal Year 2021 (HR 4049); Endless Frontier Act (H.R.6978 / S. 3832); S.Res.625 - A resolution encouraging the Government and the people of the United States to "Buy American"; Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act (S.3933); Securing America From Epidemics Act (H.R.6334); The Heroes Act (H.R.6800); Securing America's Vaccines for Emergencies (HR 6399/S. 3715); Executive Order 13922; Executive Order 13911; Executive Order 13922; Domestic manufacturing incentives; Potential amendments to PREP Act; Bring Entrepreneurial Advancements To Consumers Here In North America Act (H.R. 6690); Protecting Americans with Preexisting Conditions Act of 2019 (H.R. 986); Bayh-Dole Act; TM Act of 2020 (S.3449 / HR 6196); Pharmaceutical Accountability, Responsibility, and Transparency Act (S.3781); Protecting Our Pharmaceutical Supply Chain from China Act of 2020 (S.3537)
Client expense: Not reported · Firm income: $420,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2020 · second_quarter · Medicare/Medicaid
Discussions regarding the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills Discussions pertaining to the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019 Monitored H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored HR 1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital
Client expense: Not reported · Firm income: $130,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
S. 474, Stop the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act; H.R. 447 / S. 97, Affordable and Safe Prescription Drug Importation Act; S. 61 / H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 102 / H.R. 465, Prescription Drug Price Relief Act of 2019; H.R.1478, Affordable Insulin Act of 2019; S. 3, Keeping Health Insurance Affordable Act of 2019; H.R 965 / S. 340, CREATES Act of 2019; H.R. 1332, Fair Care Act of 2019; S. 637, CURE High Drug Prices Act; H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019; S. 657, A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits; S. 709, Prescription Drug Pricing Dashboard Act; S. 977, Transparent Drug Pricing Act of 2019; S. 1895, Lower Health Care Costs Act; H.R. 2296, FAIR Drug Pricing Act of 2019; H.R. 3947, the Competition Prescription Act of 2019; H.R. 2279, the Safe Step Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, the Prescription Drug Pricing Reduction Act of 2019; H.R. 19 / S. 3129, the Lower Costs, More Cures Act of 2019
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
2020 · second_quarter · Health Issues
Primary Care Enhancement Act CMS Primary Cares Demonstration HR 3708 To amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes. HR 856 Physician Pro Bono Care Act of 2019 HR 603 Health Savings Account Expansion Act of 2019 HR 457 Health Savings Account Act S 12 Health Savings Act of 2019 HR 3594 Healthcare Freedom Act of 2019 HR 1332 Fair Care Act of 2019
Client expense: Not reported · Firm income: $15,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.
Client expense: $2,160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · second_quarter · Health Issues
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 1035, Prescription Drug Price Transparency Act H.R. 1332, Fair Care Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1409, To promote transparency in health care pricing H.R. 2778, Healthy Maternity and Obstetric Medicine Act S. 1481, Healthy Maternity and Obstetric Medicine Act H.R. 2803, Access to Infertility Treatment and Care Act H.R. 3523, End Price Gouging for Medications Act S. 1987, End Price Gouging for Medications Act H.R. 3815, PrEP Access and Coverage Act H.R. 4158, CURE High Drug Prices Act H.R. 4493, Federal Employee Short-Term Disability Act H.R. 5551, Ensuring Child Health Coverage Compensation in Divorce Act of 2020 H.R. 6411, Emergency Advance Refill Notification Act of 2020 H.R. 6824, To amend the Internal Revenue Code of 1986 to provide for the carryover of the remaining 2020 balance in health flexible spending arrangements H.R. 7008, Family Savings Flexibility Act
Client expense: $220,000 · Firm income: Not reported
Government targets: Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Federal Communications Commission (FCC), Federal Retirement Thrift Investment Board, Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Merit Systems Protection Board, Natl Park Service (NPS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Special Counsel, Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Customs & Border Protection
2020 · second_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855: Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953: Pandemic Responder Service Award Act Phase 4 COVID-19 relief legislation COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Telehealth legislation/The Health Care at Home Act (H.R. 6644/S. 3741) H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $13,521 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · second_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855: Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953: Pandemic Responder Service Award Act Phase 4 COVID-19 relief legislation COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Telehealth legislation/The Health Care at Home Act (H.R. 6644/S. 3741) H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $13,521 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · second_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855: Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953: Pandemic Responder Service Award Act Phase 4 COVID-19 relief legislation COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Telehealth legislation/The Health Care at Home Act (H.R. 6644/S. 3741) H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $243,713 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · second_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 H.R. 5855: Bipartisan Solution to Cyclical Violence Act of 2020 H.R. 6953: Pandemic Responder Service Award Act Phase 4 COVID-19 relief legislation COVID-Safely Returning to Work and School in the Fall COVID-PPE Shortages Mental Health Issues Health Care Disparities Telehealth legislation/The Health Care at Home Act (H.R. 6644/S. 3741) H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act H.R. 7255 - Coronavirus Health Care Worker Wellness Act S. 3741 - Health Care at Home Act S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $243,713 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · first_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
2020 · first_quarter · Health Issues
Preserve Access to Affordable Generics Act (S. 64); Regulatory exclusivity; Drug pricing; Medicare Part B international reference pricing; Protecting Consumer Access to Generic Drugs Act of 2019 (H.R. 1499); Generic drug competition; Drug patent issues; Proposed rule on rebate safe Harbor (84 Fed. Reg. 2340); Lower Health Care Costs Act of 2019 (S. 1895); STOP Stalling Act (S. 1224); Affordable Prescriptions for Patients Act of 2019 (S. 1416); Preserve Access to Affordable Generics and Biosimilars Act (H.R.2375); Drug importation; State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019 (H.R. 2038); Transparent Drug Pricing Act of 2019 (S.977); Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 (S. 2161); Medicare Negotiation and Competitive Licensing Act of 2019 (H.R. 1046); Direct to consumer advertising; Medicare Prescription Drug Price Negotiation Act of 2019 (H.R. 275); Medicare Drug Price Negotiation Act (H.R. 448); Lower Drug Costs Now Act of 2019 (H.R. 3); Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019 (S.476); Fair Care Act of 2019 (H.R.1332); Prescription Drug Pricing Reduction Act of 2019 (S. 2543); Competition Prescription Act of 2019 (H.R. 3947); Fixing Global Freeloading Act (H.R. 2209); Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (HR 5133/HR 4398); STOP GAMES Act of 2019 (HR 2387);; H.R.3666 - STRONGER Patents Act of 2019, H.R.19 - Lower Costs, More Cures Act of 2019, Pharmaceutical Independence Long-Term Readiness Reform Act (HR 4710); H.R. 3991 - Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019; Purple Book Continuity Act of 2019 (H.R. 1520); Biologic Patent Transparency Act (S. 659); Conditional Approval Act (S. 3133); Fairness in Orphan Drug Exclusivity Act (H.R. 4712 / S. 3271); Orange Book Transparency Act of 2019 (H.R. 1503); Prescription Drug Affordability and Access Act (S. 3166); Biosimilars user fees legislation; Lowering Prescription Drug Prices for Americas Seniors and Families Act (S. 3384); Anticompetitive Exclusionary Conduct Prevention Act of 2020 (S. 3426); Second Look at Drug Patents Act of 2019 (S. 1617); Priority review vouchers; MODERN Labeling Act of 2020 (HR 5668); CARES Act (HR 748/S. 3548); Recall Unsafe Drugs Act of 2020 (HR 5578); Buy American Executive Order; Compulsory licensing; Strengthening Innovation in Medicare and Medicaid Act (H.R. 5741), No Ban Act (H.R. 2214/S. 1123); Benefit and Payment Parameters; Notice Requirement for Non-Federal Governmental Plans (85 Fed. Reg. 7088); Mitigating Emergency Drug Shortages Act (MEDS Act) (S. 2723); Medical Supply Chain Security Act (S. 3343); Strengthening America's Supply Chain and National Security Act (S. 3538) Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), Drug recalls, registration and listing, shortages, and supply chain reporting; Strategic National Stockpile.
Client expense: Not reported · Firm income: $260,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2020 · first_quarter · Health Issues
H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 1035, Prescription Drug Price Transparency Act H.R. 1332, Fair Care Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1409, To promote transparency in health care pricing H.R. 2778, Healthy Maternity and Obstetric Medicine Act S. 1481, Healthy Maternity and Obstetric Medicine Act H.R. 2803, Access to Infertility Treatment and Care Act H.R. 3523, End Price Gouging for Medications Act S. 1987, End Price Gouging for Medications Act H.R. 3815, PrEP Access and Coverage Act H.R. 4158, CURE High Drug Prices Act H.R. 4493, Federal Employee Short-Term Disability Act H.R. 5551, Ensuring Child Health Coverage Compensation in Divorce Act of 2020 H.R. 6411, To amend the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide notices relating to prescription drug refills to individuals covered under such plans or coverage who reside in emergency areas during emergency periods
Client expense: $250,000 · Firm income: Not reported
Government targets: Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Federal Communications Commission (FCC), Federal Retirement Thrift Investment Board, Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Merit Systems Protection Board, Natl Park Service (NPS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of Special Counsel, Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Customs & Border Protection
2020 · first_quarter · Medicare/Medicaid
H.R. 107, Burgess: Rebate cap, regarding all bio-pharmaceutical related provisions. H.R. 275, Medicare Prescription Drug Negotiation Act, regarding all bio-pharmaceutical related provisions. H.R. 366, Insulin Access for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1034, D. Collins/S. 640, Kennedy: Phair Pricing Act - Share the savings, regarding all bio-pharmaceutical related provisions. H.R. 1035, Prescription Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1332, Fair Care Act, regarding all bio-pharmaceutical related provisions. H.R. 1346, Medicare Buy-In and Health Care Stabilization Act, regarding all bio-pharmaceutical related provisions. H.R. 1384, Medicare for All Act, regarding all bio-pharmaceutical related provisions. H.R. 1781, Payment Commission Data Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1788, Limits the penalty for Part B late enrollment to 15 percent and twice the period of no enrollment, regarding all bio-pharmaceutical related provisions. H.R. 2087, Reporting drug pricing information to Medicare, regarding all bio-pharmaceutical related provisions. H.R. 2113, Prescription STAR Act, regarding all bio-pharmaceutical related provisions. H.R.3, Lower Drug Costs Now Act of 2019, regarding all bio-pharmaceutical related provisions S. 62, Empowering Medicare Seniors to Negotiate Drug Prices, regarding all bio-pharmaceutical related provisions. S. 99, Medicare Drug Price Negotiation Act, regarding all bio-pharmaceutical related provisions. S. 205, Right Rebate Act, regarding all bio-pharmaceutical related provisions. S. 377/H.R. 1046, Medicare Negotiation and Competitive Licensing Act, regarding all bio-pharmaceutical related provisions. S. 470, Medicare at 50 Act, regarding all bio-pharmaceutical related provisions. S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 , regarding all bio-pharmaceutical related provisions. S. 475, RxCAP Act, regarding all bio-pharmaceutical related provisions. S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU Act) of 2019, regarding all bio-pharmaceutical related provisions. S. 551, REFUND Act of 2019, regarding all bio-pharmaceutical related provisions. S. 691, Expands Part D OOP assistance for low-income seniors and individuals with disabilities, regarding all bio-pharmaceutical related provisions. S. 801/H.R. 1781, Allows MedPAC and MACPAC to have access to information on drug rebates, regarding all bio-pharmaceutical related provisions. S. 981, Medicare-X Choice Act of 2019, regarding all bio-pharmaceutical related provisions. Pending rule to change the Rebate Safe Harbor, regarding all bio-pharmaceutical related provisions. H.R. 1839, Medicaid Services Investment and Accountability Act, regarding all bio-pharmaceutical related provisions H.R. 2452, Medicare for America Act, regarding all bio-pharmaceutical related provisions H.R. 3107, Improving Seniors Timely Access to Care Act, regarding all bio-pharmaceutical related provisions H.R. 3327, Drug Price Transparency for Medicare Patients Act, regarding all bio-pharmaceutical related provisions S. 1261/H.R. 2463, Choose Medicare Act, regarding all bio-pharmaceutical related provisions S. 1497, Health Care Price Check Act, regarding all bio-pharmaceutical related provisions S. 2081, a bill to require drug manufacturers to provide rebates for drugs furnished under Medicare Part B for which the growth in average sales price has exceeded inflation, regarding all bio-pharmaceutical related provisions. S. 2543, Prescription Drug Pricing Reduction Act of 2019, regarding all bio-pharmaceutical provisions. H.R. 19/S.3129 , Lower Costs, More Cures Act of 2019, regarding all bio-pharmaceutical related provisions H.R. 6218/S. 3457, Preserving Patient Access to Home Infusion Act, regarding all bio-pharmaceutical related provisions No Bill, Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.
Client expense: $540,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)
2020 · first_quarter · Health Issues
Primary Care Enhancement Act CMS Primary Cares Demonstration HR 3708 To amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes. HR 856 Physician Pro Bono Care Act of 2019 HR 603 Health Savings Account Expansion Act of 2019 HR 457 Health Savings Account Act S 12 Health Savings Act of 2019 HR 3594 Healthcare Freedom Act of 2019 HR 1332 Fair Care Act of 2019
Client expense: Not reported · Firm income: $15,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
S. 474, Stop the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act; H.R. 447 / S. 97, Affordable and Safe Prescription Drug Importation Act; S. 61 / H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 102 / H.R. 465, Prescription Drug Price Relief Act of 2019; H.R.1478, Affordable Insulin Act of 2019; S. 3, Keeping Health Insurance Affordable Act of 2019; H.R 965 / S. 340, CREATES Act of 2019; H.R. 1332, Fair Care Act of 2019; S. 637, CURE High Drug Prices Act; H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019; S. 657, A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits; S. 709, Prescription Drug Pricing Dashboard Act; S. 977, Transparent Drug Pricing Act of 2019; S. 1895, Lower Health Care Costs Act; H.R. 2296, FAIR Drug Pricing Act of 2019; H.R. 3947, the Competition Prescription Act of 2019; H.R. 2279, the Safe Step Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; S. 2543, the Prescription Drug Pricing Reduction Act of 2019; H.R. 19 / S. 3129, the Lower Costs, More Cures Act of 2019
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
2020 · first_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $17,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · first_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $17,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · first_quarter · Medicare/Medicaid
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $232,658 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · first_quarter · Health Issues
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA) PL 116-127/H.R. 6201 - Families First Coronavirus Response Act H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 1895 - Lower Health Care Costs Act H.R. 5800 - Ban Surprise Billing Act H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act H.R. 3630 - No Surprises Act H. R. 8 - Bipartisan Background Checks Act of 2019 H. R. 1418 - Competitive Health Insurance Reform Act of 2019 S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019 S. 966 - Medicare Care Coordination Improvement Act of 2019 S. 2372 - VA MISSION Act of 2018 S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019 H. R. 1379 - Ensuring Lasting Smiles Act H. R. 207 - Stop the Violence Act of 2019 H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction) H. R. 1041 - Critical Access Hospital Relief Act of 2019 H.R. 3656/S. 1350 - ACCESS Act of 2019 H.R. 861 End Surprise Billing Act H.R. 3630 No Surprises Act H.R. 3502 Protecting People from Surprise Medical Bills Act H.R. 2550 - Prevent BLEEDing Act of 2019 H. R. 2143 - Promoting Integrity in Medicare Act of 2019 H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 H. R. 1332 - Fair Care Act of 2019 H.R. 2464 - End the Cycle of Violence Act of 2019 S. 1895 Lower Health Care Costs Act S. 967 Reducing Costs for Out of Network Services Act S. 1266 Protecting Patients from Surprise Medical Bills Act S. 1531 Stopping the Outrageous Practice of Surprise Bills Act S. 1607 Medical Billing Fairness Act H. R. 1763/S. 348 - Resident's Physician Shortage Reduction Act S. 1350 - Good Samaritan Health Professionals Act H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019 Cures 2.0 E/M Global Code Issues Unique Patient Identifier Lower Health Care Costs Act Compromise Bleeding Control for the Injured (Stop The Bleed campaign) Qualified clinical data registry (QCDR) Firearms Safety and Research MACRA Implementation Merit-based Incentive Payment Systems (MIPS) Alternative Payment Models (APM) Outpatient Prospective Payment System (OPPS) Common Rule Medicare for All National Trauma Systems Legislation Drug Pricing Patient-Centered Outcomes Research Institute (PCORI) Measuring Surgical Quality Medicare Physician Reimbursement Cancer Research and Funding Trauma Research and Funding Opioids/Pain Management Legislation ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency) Reauthorization of Patient-Centered Outcomes Research Institute (PCORI) 2020 CMS Proposed Fee Schedule Rare earth magnet legislation
Client expense: $232,658 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
2020 · first_quarter · Medicare/Medicaid
HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019 Monitored H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored HR 1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital
Client expense: Not reported · Firm income: $130,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Defense
S. 2154 S. 2115 S. 2109 S. 2060 S. 2058 S. 2052 S. 1991 S. 1860 S. 1800 S. 1799 S. 1798 S. 1790 S. 1789 S. 1771 S. 1761 S. 1690 S. 1680 S. 1679 S. 1615 S. 1580 S. 1555 S. 1542 S. 1534 S. 1526 S. 1513 S. 1512 S. 1511 S. 1503 S. 1501 S. 1500 S. 1498 S. 1495 S. 1493 S. 1471 S. 1467 S. 1413 S. 1383 S. 1360 S. 1348 S. 1320 S. 1316 S. 1271 S. 1237 S. 1229 S. 1218 S. 1215 S. 1156 S. 1143 S. 1136 S. 1096 S. 1049 S. 986 S. 974 S. 965 S. 871 S. 858 S. 703 S. 675 S. 645 S. 622 S. 401 S. 373 S. 208 S. 191 S. 164 S. 114 S. 98 S. 30 S.J.Res. 10 S.Res. 160 S.Res. 72 S.Res. 24 S.Res. 11 S.Res. 42 H.R. 1553 H.R. 2565 H.R. 489 H.Res. 403 H.R. 3746 H.R. 2970 H.R. 2942 H.R. 2941 H.R. 2195 H.R. 2056 H.R. 1779 H.R. 1092 H.R. 955 H.R. 2326 H.J.Res. 46 H.R. 1293 H.R. 3611 H.R. 3038 H.R. 2495 H.R. 3306 H.R. 2795 H.R. 3458 H.R. 2945 H.R. 1891 H.R. 3161 H.Con.Res. 18 S.Con.Res. 3 H.R. 2406 H.R. 3802 H.R. 2342 H.R. 1090 H.R. 814 H.R. 2022 H.R. 2689 H.R. 1076 H.R. 1931 H.R. 112 H.R. 3420 H.R. 2098 H.R. 1078 H.R. 1893 H.R. 2483 H.R. 2226 H.R. 3524 H.R. 3508 H.R. 336 H.R. 1837 H.R. 3576 H.R. 3064 H.R. 2949 H.R. 2419 H.R. 2354 H.R. 1653 H.R. 910 H.Res. 442 H.Res. 309 H.Res. 302 H.Res. 214 H.R. 2166 H.R. 618 H.R. 2979 H.R. 3190 H.R. 1193 H.R. 1810 H.R. 2904 H.R. 442 H.R. 1332 H.R. 3652 H.R. 3840 H.R. 3801 H.R. 3727 H.R. 3724 H.R. 3658 H.R. 3588 H.R. 3567 H.R. 3505 H.R. 3467 H.R. 3400 H.R. 3313 H.R. 3309 H.R. 3266 H.R. 3247 H.R. 3227 H.R. 3226 H.R. 3216 H.R. 3191 H.R. 3186 H.R. 3185 H.R. 3181 H.R. 3177 H.R. 3176 H.R. 3175 H.R. 3174 H.R. 3173 H.R. 3166 H.R. 3148 H.R. 3143 H.R. 3137 H.R. 3132 H.R. 3093 H.R. 3087 H.R. 3084 H.R. 3065 H.R. 3046 H.R. 3045 H.R. 3041 H.R. 3034 H.R. 3015 H.R. 2954 H.R. 2953 H.R. 2952 H.R. 2944 H.R. 2937 H.R. 2907 H.R. 2892 H.R. 2880 H.R. 2869 H.R. 2814 H.R. 2811 H.R. 2794 H.R. 2767 H.R. 2762 H.R. 2759 H.R. 2756 H.R. 2598 H.R. 2555 H.R. 2554 H.R. 2450 H.R. 2432 H.R. 2395 H.R. 2330 H.R. 2255 H.R. 2254 H.R. 2253 H.R. 2252 H.R. 2249 H.R. 2171 H.R. 2091 H.R. 2033 H.R. 1863 H.R. 1801 H.R. 1792 H.R. 1746 H.R. 1714 H.R. 1638 H.R. 1462 H.R. 1403 H.R. 1258 H.R. 1086 H.R. 1032 H.R. 1019 H.R. 1017 H.R. 914 H.R. 859 H.R. 853 H.R. 700 H.R. 620 H.R. 613 H.R. 563 H.R. 553 H.R. 491 H.R. 463 H.R. 351 H.R. 344 H.R. 311 H.R. 248 H.R. 238 H.Con.Res. 49 H.Con.Res. 43 H.Res. 468 H.Res. 440 H.Res. 361 H.Res. 229 H.Res. 219 H.Res. 177 H.Res. 134 H.Res. 126 H.Res. 124 H.Res. 99 H.Res. 96 H.Res. 29 S. 252 H.R. 2500 H.R. 2257 H.R. 1567 H.R. 2016 H.R. 3626 H.R. 3233 H.R. 2727 H.R. 2707 H.R. 2280 H.R. 2060 H.R. 1795 H.R. 1249 H.R. 1231 H.R. 1004 H.R. 889 H.R. 2987 H.R. 2028 H.Res. 413 H.R. 2388 H.R. 3014 H.R. 3517 H.R. 3178 H.R. 3072 H.R. 2947 H.R. 2886 H.R. 2618 H.R. 2617 H.R. 1911 H.R. 663 H.R. 333 H.R. 303 H.Res. 455 H.Res. 269 H.Res. 39 H.R. 2384 H.R. 2401 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 2400 H.R. 1094 H.R. 3112 H.R. 1565 H.R. 1678 H.R. 3042 H.R. 1201 H.R. 1966 H.R. 1183 H.R. 3219 H.R. 2699 H.Res. 288 H.R. 2803 H.R. 3815 H.R. 3429 H.R. 3416 H.R. 2371 H.R. 2501 H.R. 3523 H.R. 1384
Client expense: Not reported · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Archives & Records Administration (NARA), Navy, Dept of, SENATE, U.S. Coast Guard (USCG), Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
2019 · fourth_quarter · Medicare/Medicaid
HR1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills S 2543 Prescription Drug Pricing reduction Act, Sec. 109 Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019 Monitored HR 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR1559 The 340B Protection and Accountability Act of 2019 Monitored HR1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost sharing obligations for treatments provided by the hospital
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE